Immunomedics, Inc. (Nasdaq: IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that three presentations will be given at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO), scheduled for June 1 - 5, 2007, in Chicago, Illinois. [click link for full article]
More...